2014Journal of clinical and experimental medicineRequires access

The curative observation of cyclosporine combined with danazol in the treatment of refractory idiopathic thrombocytopenic purpura

Liu Chuan-ca

Open publisher page 0 citations

Abstract

Objective To investigate the clinical effect of cyclosporine A( CSA) combined with danazol in the treatment of refractory idiopathic thrombocytopenic purpura( ITP). Methods 45 patients with refractory ITP were randomly divided into two groups,the control group( n = 21 cases) was treated with vincristine and cyclophosphamide,and the observation group( n = 24 cases) was treated with CSA combined with danazol. Two groups were treated for 3 months. The clinical effect and the rate of adverse reaction of two groups were compared. Results The total efficiency of the observation group( 79. 2%) was significantly higher than that of the control group( 66. 7%)( P 0. 05); and there was no significant difference between the rate of adverse reaction in two groups during the treatment( 45. 8%,47. 6%)( P 0. 05). Conclusion The treatment of CSA combined with danazol for refractory ITP had a significantly effect,safe and reliable. It was worthy of clinical application.

About this research paper

What this paper is about

Objective To investigate the clinical effect of cyclosporine A( CSA) combined with danazol in the treatment of refractory idiopathic thrombocytopenic purpura( ITP). Methods 45 patients with refractory ITP were randomly divided into two groups,the control group( n = 21 cases) was treated with vincristine and cyclophosphamide,and the observation group( n = 24 cases) was treated with CSA combined with danazol. Two groups were treated for 3 months. The clinical effect and the rate of adverse reaction of two groups were compared. Results The total efficiency of the observation group( 79. 2%) was significantly higher than that of the control group( 66. 7%)( P 0. 05); and there was no significant difference between the rate of adverse reaction in two groups during the treatment( 45. 8%,47. 6%)( P 0. 05). Conclusion The treatment of CSA combined with danazol for refractory ITP had a significantly effect,safe and reliable. It was worthy of clinical application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical effect of cyclosporine A( CSA) combined with danazol in the treatment of refractory idiopathic thrombocytopenic purpura( ITP). Methods 45 patients with refractory ITP were randomly divided into two groups,the control group( n = 21 cases) was treated with vincristine and cyclophosphamide,and the observation group( n = 24 cases) was treated with CSA combined with danazol. Two groups were treated for 3 months. The clinical effect and the rate of adverse reaction of two groups were compared. Results The total efficiency of the observation group( 79. 2%) was significantly higher than that of the control group( 66. 7%)( P 0. 05); and there was no significant difference between the rate of adverse reaction in two groups during the treatment( 45. 8%,47. 6%)( P 0. 05). Conclusion The treatment of CSA combined with danazol for refractory ITP had a significantly effect,safe and reliable. It was worthy of clinical application.

Key concepts: Danazol, Medicine, Refractory (planetary science), Thrombocytopenic purpura, Adverse effect, Cyclophosphamide, Vincristine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The curative observation of cyclosporine combined with danazol in the treatment of refractory idiopathic thrombocytopenic purpura — Research Paper | ScholarLens